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RESEARCH

Open Access

The effects of perinatal testosterone exposure on
the DNA methylome of the mouse brain are
late-emerging
Negar M Ghahramani1,2†, Tuck C Ngun1,2†, Pao-Yang Chen3, Yuan Tian4, Sangitha Krishnan1,2, Stephanie Muir1,2,
Liudmilla Rubbi5, Arthur P Arnold2,6, Geert J de Vries7, Nancy G Forger7, Matteo Pellegrini5 and Eric Vilain1,2,8*

Abstract
Background: The biological basis for sex differences in brain function and disease susceptibility is poorly understood.
Examining the role of gonadal hormones in brain sexual differentiation may provide important information about sex
differences in neural health and development. Permanent masculinization of brain structure, function, and disease is
induced by testosterone prenatally in males, but the possible mediation of these effects by long-term changes in the
epigenome is poorly understood.
Methods: We investigated the organizational effects of testosterone on the DNA methylome and transcriptome in two
sexually dimorphic forebrain regions—the bed nucleus of the stria terminalis/preoptic area and the striatum. To study the
contribution of testosterone to both the establishment and persistence of sex differences in DNA methylation, we
performed genome-wide surveys in male, female, and female mice given testosterone on the day of birth. Methylation
was assessed during the perinatal window for testosterone's organizational effects and in adulthood.
Results: The short-term effect of testosterone exposure was relatively modest. However, in adult animals the number of
genes whose methylation was altered had increased by 20-fold. Furthermore, we found that in adulthood, methylation at
a substantial number of sexually dimorphic CpG sites was masculinized in response to neonatal testosterone exposure.
Consistent with this, testosterone's effect on gene expression in the striatum was more apparent in adulthood.
Conclusion: Taken together, our data imply that the organizational effects of testosterone on the brain methylome and
transcriptome are dramatic and late-emerging. Our findings offer important insights into the long-term molecular effects
of early-life hormonal exposure.
Keywords: Brain sexual differentiation, Epigenetic modifications, DNA methylation, Testosterone, Organizational effects

Background
The biological basis for sex differences in brain function
and disease susceptibility is poorly understood. Numerous neurological disorders (e.g., autism, schizophrenia,
Parkinson's disease) show sexual dimorphism in prevalence [1-3], and sex-specific biological factors are likely
to be major contributors. Sex steroid hormones such as
testosterone play a major role in sexually dimorphic
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brain development [4,5]. Exposure of neural tissue to
testosterone and estradiol, its aromatized form, during
the perinatal window (‘the sensitive period’), leads to
long lasting and irreversible masculinization of the brain
[6]. The fundamental molecular mechanisms underlying
the hormonal regulation of brain sexual differentiation
remain understudied.
Emerging evidence implicates DNA methylation as an
important player in a variety of critical nervous system
functions [7-9]. 5-Methylcytosine (5-mC) marks at CpG
islands in gene promoters are known to affect gene transcription [10], modulate X inactivation and imprinting,
and regulate heterochromatin [11]. There is also increasing evidence of the importance of non-CpG methylation
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in neural development [12,13]. Recent studies have identified CpGs that show sex-specific methylation that can
be modified by sex steroids during the sensitive period.
Estradiol can alter the methylation status of CpG sites
on the promoters of the estrogen and progesterone receptor genes [14,15]. However, the methylation status of
only a limited number of CpG sites at candidate genes
has been studied. A larger-scale study of the methylome
could elucidate the role of epigenetic modifications in
hormone-induced brain sexual differentiation.
We hypothesized that long-term effects of gonadal
steroid hormones on brain development involve epigenetic modifications. We investigated the scope and properties of testosterone's organizational effects on neural
DNA methylation and gene expression by comparing
the methylome and transcriptome in male (XY), female
(XX), and female mice that received testosterone on the
day of birth (XX + T). Genome-wide methylation and
expression profiling were carried out for two sexually dimorphic brain regions: the striatum and the combined
bed nucleus of the stria terminalis and preoptic area
(BNST/POA). These regions were chosen as both are responsive to gonadal hormones and show strong sexual
dimorphisms. The BNST/POA is subject to long-lasting
irreversible neuroanatomical changes due to perinatal
testosterone exposure and has been implicated in the
regulation of male copulatory behavior, gonadotropin release, and stress modulation [16]. The striatum is involved in dopaminergic function and reward and shows
several key sex differences, many of which are caused by
gonadal hormones. Numerous aspects of dopamine metabolism are influenced by estrogen [17-20]. Furthermore, we have previously shown that Sry (the Y-linked
male sex determination gene) enhanced striatum dopamine release and regulated sensorimotor functions of
dopaminergic neurons [21]. To examine the long-term
molecular effects of organizational testosterone, we examined two different time points: postnatal day (PN) 4,
which is during the sensitive period, and adulthood
(PN60).
We show that neonatal testosterone treatment of females induces a shift in the methylome from a femaletypical to a more male-typical pattern. Contrary to our
expectations, the shift toward the male pattern is only
observed during adulthood. Organizational testosterone
also affects the CpG methylation status of many more
genes at PN60 than at PN4. Consistent with the CpG
methylation analysis, testosterone's effects on gene expression in the striatum were more apparent in adulthood. Our data demonstrate that the organizational
effects of testosterone on the brain methylome and transcriptome are dramatic and late-emerging. They suggest
an important role for CpG methylation in brain sexual
organization.
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Methods
Animals and neonatal injections

This study was approved by the University of California,
Los Angeles (UCLA) Committee on Animal Research
and was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. C57BL/6 J
female and male mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) and housed at the
UCLA Animal Care Facility. Animals were maintained
at 20°C with a 12-h light/12-h dark cycle, provided ad
libitum with food and water, and allowed to acclimate
for 1 week before initiation of experiments. Female mice
were mated and once pregnant, cages were checked daily
for pups.
On the day of birth, PN0, male pups (referred to as
XY throughout this paper) were treated subcutaneously
with 15 μl of peanut oil vehicle; female pups were either
treated subcutaneously with 15 μl oil (XX) or with
100 μg testosterone propionate (Sigma-Aldrich, St.
Louis, MO, USA) in 15 μl oil (XX + T). Half of the mice
in each group were sacrificed at PN4 during the perinatal sensitive period for sexual differentiation and just
prior to the sexually dimorphic cell death known to be
important for differentiation of the POA and BNST
[22,23]. The remaining mice in each group were sacrificed in early adulthood, on PN60. In order to eliminate
group differences in pubertal or adult gonadal hormone
exposure, mice euthanized on PN60 were gonadectomized at PN21 (i.e., prior to puberty) and implanted
with a 5-mm-long Silastic capsule (inner diameter,
1.57 mm; outer diameter, 2.41 mm) filled with testosterone at around the time of puberty (PN45). This design
allows us to attribute any differences between XX and
XX + T mice only to the neonatal hormone exposure.
Post-weaning, animals belonging to the same litter were
housed in the same cage (maximum of three animals per
cage), although males and females were separated. As all
pups in a litter received the same treatment (either T or
vehicle), all adult animals housed in the same cage had
undergone the same hormonal manipulations.
We had a total of 12 experimental groups: XX, XY,
and XX + T tissue from two ages and two distinct brain
regions. Each experimental group had two biological
replicates, each comprising a pool of tissue from three
animals, making for a total of 24 samples.
Brain dissections

At PN4 or PN60, whole brain was rapidly removed from
the skull and brain regions of interest were dissected
under a microscope on an ice-cold slide. After removal
of the dura mater, two cuts through the brain along the
coronal plane were made. The first was at the midpoint
of the optic chiasm (0.14 mm anterior to bregma) and

Ghahramani et al. Biology of Sex Differences 2014, 5:8
http://www.bsd-journal.com/content/5/1/8

the second was where the optic tract enters the brain
(0.58 mm posterior to bregma). The resulting slab of tissue was then placed posterior side down. The BNST/
POA was defined as the region ventral to the lateral ventricle and bounded laterally by the medial edge of the internal capsule. The striatum was defined as the tissue
between the external capsule and the anterior commissure, bounded laterally by the cortex and medially by the
internal capsule. After dissection, the tissue was immediately placed on dry ice and stored at −80°C until it was
processed for downstream experiments.
Measurement of levator ani and bulbocavernosus muscles

The dose of testosterone used in this study has previously been shown to completely masculinize BNST volume and cell number [24]. To confirm the efficacy of
hormone treatments here, we randomly selected a subset
of the XX (N = 4) and XX + T (N = 5) mice on PN4 and
examined the size of the androgen-sensitive levator ani
and bulbocavernosus muscles. The perineums were
processed as described previously [25], and the maximal
cross-sectional area of the levator ani was determined
by tracing around the muscle using StereoInvestigator
(MBF Biosciences, Williston, VT, USA) software.
Reduced representation bisulfite sequencing library
construction

Genomic DNA from mouse brains was extracted for
making reduced representation bisulfite sequencing
(RRBS) libraries following the standard RRBS protocol
[26]. The genome was digested with the MspI enzyme,
a methylation-insensitive restriction enzyme. These
MspI-digested samples were ligated with Illumina
adaptors (Illumina Inc., San Diego, CA, USA) and sizeselected. Fragments from 100 to 200 bases were selected as these are enriched for CpG-rich regions, such
as CpG islands, promoter regions, and enhancer elements. In total we selected 500 K distinct fragments
for sequencing. These fragments were denatured and
treated with sodium bisulfite to reveal their methylation status (CpGenome Universal DNA Modification
Kit, Cat. No. S7820, Millipore, Billerica, MA, USA).
Libraries were then polymerase chain reaction (PCR)-amplified with MyTaqHS (BIO-25047, Bioline, Taunton, MA,
USA) and sequenced using the Solexa sequencing technology (Illumina Hiseq 2000 sequencers). The reads were
aligned to the reference genome (mouse mm9) using the
modified bisulfite aligner, BS Seeker [27]. To generate
genome-wide DNA methylation profiles, we calculated the
methylation level for each covered cytosine on the genome.
As bisulfite treatment converted unmethylated cytosines
(Cs) to thymines (Ts), we estimated the methylation level at
each cytosine by #C/(#C + #T), where #C is the number of
methylated reads and #T is the number of unmethylated
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reads. This number represents the average methylation
level at that particular site across the cell population tested.
In this study we only included cytosines that were covered
by at least four reads for the analysis.
Identifying differentially methylated regions and
differentially methylated genes

We first searched for differentially methylated regions
(DMRs) that showed significant differential methylation.
We grouped nearby cytosine sites into units called fragments. In each pairwise comparison, a Student's t test
was performed at each site to quantify the difference between the groups at that site. This generated a t-score
that represented the difference between the groups (the
larger the t-scores, the more different the methylation
levels in that pairwise comparison). In order to get an
accurate measurement of these differences after the sites
were combined into fragments, the t-scores of all sites in
that fragment are averaged to produce a z-score. To
qualify as DMRs, the fragment had to (1) show a difference of ≥10% in mean methylation level between the
two groups being compared, (2) have at least three cytosines for which methylation levels were observed in all
relevant samples, and (3) have a z-score below a threshold relevant to that comparison. The selection of the
z-score threshold was based on the false discovery rate
estimated by comparing the real data to simulated
methylomes as the control for false discovery rate (FDR)
computation (full procedure below). These DMRs were
then associated with a gene if there was a transcription
start site within 5 kb of them or if they overlapped with any
known genes to identify differentially methylated genes. We
used GeneVenn (http://genevenn.sourceforge.net/, [28]) to
determine overlap between gene sets.
Estimating false discovery rate

To assess the false discovery rate for our DMRs, we constructed simulated methylomes, with the same read
coverage per site as the real samples. For each CG site
in each simulated sample, we then simulated the reads
(C if methylated or T if unmethylated) based on the
average methylation level (Pm) from all real samples at
this CG site. The number of methylated reads (Cs) at a
site of coverage n is a random sample from the binomial
distribution B(n, Pm). We repeated our simulation of
reads throughout the genome for all samples. The resulting samples had the same average methylation levels as
the real sample. Since the reads were simulated from the
binomial distribution with the same average methylation
levels as in the real samples, the differences in methylation patterns across genes, repeats, promoters, etc. were
preserved. The simulated data has the same coverage as
the real samples so the statistical power is not affected.
The simulated methylomes should have no difference in
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methylation levels between the two comparison groups
(i.e., no DMRs), since they are all selected using the
same methylation frequency. Any DMRs (and the DMRassociated genes) identified from these simulated samples are thus considered false positives. Then, for each
comparison we repeated the whole procedure to detect
the DMR on simulated samples: we first performed t tests
on individual sites and then summarized the t-scores per
fragment with a z-score. For each z-score threshold, we
computed the numbers of DMRs that were found in the
simulated data to those found in the real data. We used the
ratio of these to compute the FDR. We chose a z-score
threshold that resulted in a false discovery rate less than
10% in all comparisons.
Traditional (Sanger) bisulfite sequencing

Strand-specific primers were designed for the bisulfiteconverted genome of the region of interest and synthesized by Life Technologies (Carlsbad, CA, USA). For
Micall1 (target region, chr15:78965961–78966079; negative strand, mm9), the forward primer was ATTTTTGT
TATTGGGAAGGATAAGG and the reverse primer was
AAACCCCAACCATACATAATCTCTA. The cycling conditions were 1 cycle at 95°C for 2 min; 35 cycles at 95°C for
30 s, 58°C for 1 min, and 60°C for 1 min; and 1 cycle at
60°C for 15 min. For Fzd9 (target region, chr5:135725414–
135725524; negative strand, mm9), the forward primer was
TGAATTGATTGGGTTTTGTTATGTA and the reverse
primer was ACTAATAATACCCACCACCAAAAAC. The
cycling conditions were 95°C for 2 min; 40 cycles at 95°C
for 30 s, and 60°C for 2 min; 1 cycle at 60°C for 15 min.
The samples used for traditional bisulfite sequencing (n =
2–3 per experimental group) were not used in the RRBS
experiments although they were generated at the same
time. One microgram for each sample was bisulfite-treated
and purified (CpGenome Universal DNA Modification Kit,
Cat. No. S7820, Millipore). Forty nanograms of bisulfiteconverted DNA was used in each PCR (MyTaqHS, BIO25047, Bioline). After gel purification, amplicons were
cloned into pCR4-TOPO TA vectors (TOPO TA Cloning
Kit for Sequencing, K4575-01SC, Life Technologies).
Fifteen to twenty colonies were sent for Sanger sequencing using the M13R primer (Laragen Inc., Culver City,
CA, USA).
Heat maps of methylation levels in differentially
methylated regions

A union set of DMRs was collected from all pairwise
comparisons (all ages, sex, and regions). Among them,
we selected 4,086 DMRs that were extremely differentially
methylated (longer than 50 bp, delta methylation ≥25%,
and –z-score ≥3.5). These are potentially regions that
are susceptible to methylation changes. The average
methylation levels in all XX, XX + T, and XY groups
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were plotted in heat maps with hierarchical clustering
of the DMRs.
Gene ontology using Ingenuity Pathway Analysis

Functional analysis of statistically significant CpG
methylation changes was performed with Ingenuity
Pathway Analysis (IPA; Ingenuity Systems, www.ingenuity.com). Ingenuity functional analysis identified networks, canonical signaling pathways, and biological
functions and/or diseases that were most significantly affected by testosterone and age. For all analyses, datasets
containing gene identifiers and corresponding delta
methylation values were uploaded into IPA. The genes
were overlaid onto a global molecular network developed from information in the Ingenuity Pathway Knowledge Base. Networks of these focus genes were then
algorithmically generated based on their connectivity.
To identify biological functions and diseases that were
enriched in the different datasets, genes were associated
with biological functions and/or diseases in the Ingenuity Knowledge Base. Right‐tailed Fisher's exact test was
used to calculate a p value determining the probability
that each biological function and/or disease assigned to
that dataset was due to chance alone. In this method,
the p value for a given process is calculated by investigating (1) the number of participating genes in that
process and (2) the total number of genes known to be
related to that process in the selected reference set. The
more genes involved, the more significant the p value.
Canonical pathways analysis identified the pathways
from the IPA library of pathways that were most significant to the dataset. The significance of the association
between the dataset and the canonical pathway was
measured in two ways: (1) a ratio of the number of molecules from the dataset that map to the pathway divided
by the total number of molecules that map to the canonical pathway was determined and displayed in the tables
that follow; (2) Fisher's exact test was used to calculate a
p value determining the probability that the association
between the genes in the dataset and the canonical pathway was explained by chance alone.
Testosterone measurements

Samples were collected at the time of euthanasia. In all
cases, blood was obtained from the carotid artery following decapitation. Blood samples were then processed
to isolate serum and stored at −20°C until assays for
testosterone were performed. Testosterone assays using
radioimmunoassay were performed by Ligand Assay and
Analysis Core at the University of Virginia Center for Research in Reproduction (supported by NICHD (SCCPIR)
Grant U54-HD28934). Testosterone measurements were
performed in singlet reactions using Siemens Medical Solutions Diagnostics testosterone RIA (Siemens Healthcare,
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Malvern, PA, USA) with a reportable range of 47.3–
170.5 ng/L. There were no significant differences in the
measured testosterone levels between our experimental
groups using the Kruskal-Wallis one-way analysis of variance test (H = 3.8, 2 df, p = 0.15).
Processing for gene expression analysis

Total RNA samples were derived from five pools of three
animals using AllPrep DNA/RNA Micro Kit (Qiagen,
Valencia, CA, USA) according to the manufacturer's
protocol. This kit enabled simultaneous purification of
genomic DNA and total RNA from all tissues. Samples
were prepared from the same tissue samples that were
used to create the RRBS libraries. RNA was quantified
using a Ribogreen fluorescent assay (Life Technologies)
and normalized to 10 ng/μl prior to amplification.
Amplified and labeled cRNA was produced using the
Illumina specific Ambion TotalPrep kit (Applied Biosystems Inc., Foster City, CA, USA). First and second
strand cDNA were produced using the Ambion kit and
purified using a robotic-assisted magnetic capture step.
Biotinylated cRNA was produced from the cDNA template in a reverse transcription reaction. Typical yields
were in excess of 1.5 μg. After a second Ribogreen
quant and normalization step, amplified and labeled
cRNA was hybridized overnight at 58°C to MouseRef-8
v1.1 BeadChip expression arrays from Illumina. To
minimize array-to-array variability, a cRNA sample
from each of the experimental groups was hybridized
to each of the beadchips (n = 5/group) according to the
manufacturer's protocol. The MouseRef-8 v1.1 beadchip
contains over 24,000 well-annotated RefSeq transcripts and
allows eight samples to be interrogated in parallel.
Hybridization was followed by washing, blocking, staining,
and drying on the Little Dipper processor (Agilent
Technologies, Sta. Clara, CA, USA). Array chips were
scanned on either the BeadArray reader or the iScan
reader (Illumina).
Microarray data analysis of gene expression

cDNA microarray data analysis was performed using the R
software and Bioconductor packages. The raw intensity
data were first log2 transformed and then the outlier
samples were detected based on the average inter-sample
correlations. Three samples with average inter-sample correlations larger than two standard deviations (SDs) from
the mean across all samples were removed from follow-up
analysis. Then the samples were normalized by quantile
normalization. Probes were considered robustly expressed
if the detection p value was <0.05 in at least 20 samples
(the total number of samples for every genetic/treatment
group) in the dataset. After the data quality controls, 57
samples with 13,776 probes were retained for differential
expression analysis. Hierarchical clustering analysis using
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one minus inter-array correlation measures was further
performed to assess the sample clustering patterns.
Differential expression analysis was conducted using
the R limma package [29], and unless otherwise specified, the significance threshold was Benjamini-Hochberg
(BH)-adjusted p value <0.05. Limma uses linear models
to robustly assess the differential expression of genes.
Histograms of p values were plotted to show if there was
a significant differential expression signal genome-wide.
To identify the genes that differed by age in the different
groups/brain regions, the factorial design was applied
using limma linear models. The genes were identified as
showing significant dynamic changes with age if their
p values associated with the interaction term between
the factors of group and age were less than 0.005.
Quantitative reverse transcription-polymerase chain reaction

Reverse transcription was performed using the Tetro
cDNA Synthesis Kit (Bioline, catalog no. BIO-65043)
with 1 μg of total RNA as template. The RNA samples
used for validation were from the original microarray
samples contingent on availability (n = 3–4 per genotype). The sequences of PCR primers are as follows: for
Alcam, forward primer 5′-CGA ACC CTG CCT GTG
TCA TGC ACA ATA-3′ and reverse primer 5′-TAT
CGT CTG CCT CAT CGT GCT CTG GAA T-3′; for
Gapdh, forward primer 5′-TGC CGC CTG GAG AAA
CC-3′ and reverse primer 5′-CCC TCA GAT GCC
TGC TTC AC-3′; for Gatad1, forward primer 5′-GAA
ATT CAC AGA AGG TCG GC-3′ and reverse primer
5′-AAT ATA CTC CCT TGT AGA AGA TTG A-3′; for
Utx, forward primer 5′-CCA ATC CCC GCA GAG
CTT ACC T-3′ and reverse primer 5′-TTG CTC GGA
GCT GTT CCA AGT G-3′. All primers used spanned at
least one intron. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used for normalization of gene expression between samples. Quantitative reverse transcriptionpolymerase chain reactions (qRT-PCRs) were carried out in
duplicate utilizing the Sybr Green-based SensiFAST™ SYBR
& Fluorescein Kit (Bioline, catalog no. BIO-96005). The
thermocycling parameters for all reactions were 1 cycle at
95°C for 2 min, 40 cycles at 95°C for 10 s, 60°C for 10 s,
and 72°C for 10 s. We used the standard curve method to
determine relative expression and assessed significance
using the Student's t test (α = 0.05). Data are expressed as
fold change where the expression level in the XX group has
been set to 1.
Data access

The data discussed in this publication have been deposited
in NCBI's Gene Expression Omnibus and are accessible
through GEO Series accession number GSE50218 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE50218).
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The expression data generated for this study have been
submitted to the NCBI Gene Expression Omnibus (GEO;
http://www.ncbi.nlm.nih.gov/geo/) under accession number
GSE49986.

Results
Sex effects on genome-wide methylation data

To examine sex-specific and hormone-induced changes in
brain DNA methylation, we compared genome-wide maps
of DNA methylation in adult mouse striatum and BNST/
POA between XX and XY mice generated using RRBS. All
animals were gonadectomized and provided with identical
hormone replacement prior to sacrifice so that any differences seen could not be due to differences in circulating
hormones at the time of sacrifice (see ‘Methods’). We had a
total of 12 experimental groups: XX, XY, and XX + T tissue
from two ages and two distinct brain regions. Each experimental group had two biological replicates, each comprising a pool of tissue from three animals, making for a total
of 24 samples. Forty-six percent of our sequencing reads
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uniquely mapped back to the mouse genome, which resulted in an average sequencing depth of 58× at each CpG.
We assayed approximately 1.39 million CpGs in 125 million uniquely mapped reads in each sample (Additional file
1: Table S1). The majority of samples had >1 million distinct CpGs covered with a minimum of 4× coverage. CpG
sites that were not present in all comparison groups were
excluded from further analysis.
We first examined global levels of CpG, CHH, and
CHG methylation. At CHH sites, any two bases can follow the initial C, whereas at CHG sites, any base can be
in the second position but the third base must be a G.
There were no significant effects on these global levels
due to sex or hormonal treatment. However, the age of
the animal was positively correlated with methylation
level, especially at non-CG sites (CHG p = 9.19E − 8 in
the striatum, p = 1.37E − 8 in the BNST/POA; CHH p =
4.88E − 10 in the striatum, p = 6.88E − 11 in the BNST/
POA; Student's t test for all comparisons), which is consistent with recent studies [12,13] (Figure 1a,b,c). Global

Figure 1 DNA methylation patterns in XX, XY, and XX + T. Non-CpG methylation increases with age. (a) Global CpG methylation levels are
significantly higher at PN60 than PN4 in the BNST/POA but not the striatum. CHG (b) and CHH (c) methylation levels are significantly higher at
PN60 than at PN4 in both brain regions. (d, e) The heat maps show correlations between the methylation levels across all samples in the (d)
striatum and (e) BNST/POA. The diagonal axis running from the bottom left to top right corner is the line of symmetry where each sample correlates with
itself. The brightest yellow shade represents full correlation (=1) whereas the darkest red shade represents the lowest correlation value (0.98; key at top left).
Complete clustering is based on the Euclidean distance. (f–i) These heat maps show differentially methylated regions (DMRs) driven by sex and/or
testosterone at PN60. The color key shows absolute methylation level from 0% (blue) to 100% (red). The azure trace represents the moving average
of the methylation levels in the neighboring windows. (f) Autosomal DMRs in the striatum. (g) Autosomal DMRs in the BNST/POA. (h) X-linked
DMRs in the striatum. (i) X-linked DMRs in the BNST/POA.
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CpG methylation levels were significantly increased with
age in the BNST/POA (p = 5.9E − 3 by the Student's t test)
but not the striatum.
We then focused our analysis on CpG methylation.
Overall, the CpG methylation profiles of adult XX and
XY striatum and BNST/POA were highly similar across
all chromosomes (Pearson coefficient, 0.99) (Figure 1d,e),
indicating that the genomic profiles of 5-mC are highly
reproducible. Despite this overall similarity, hierarchical
clustering clearly identified sex- and testosterone-driven
(Figure 1f,g,h,i) methylation differences. Testosteronedriven differences (different in XX vs. XX + T) were
more abundant on autosomes (Figure 1f,g). In many regions showing these differences, XX + T CpG methylation patterns resemble those of XY. On the other hand,
sex-specific differences (XX vs. XY) were clearest on the
X chromosome, as expected, given the involvement of
CpG methylation in the process of X inactivation and
XX + T tended to resemble XX (Figure 1h,i).
To identify genes that undergo sex-specific methylation, we compared the methylomes of male (XY) and female (XX) mice at PN60 and found a large number of
genes that showed sex differences in methylation patterns in both the striatum (1,577 genes) and the BNST/
POA (1,026 genes) (Additional file 2: Table S2). Of the
1,577 genes in the striatum that showed sex-specific methylation, 420 were on the X chromosome and 348 (82.86%) of
these were more methylated in females (Figure 2a).
Similarly, in the BNST/POA, 426 of the 1,026 sexaffected genes were X-linked and 359 (84.27%) of these
demonstrated elevated methylation levels in females
(Figure 2b). This is likely due to X chromosome inactivation in females [30,31]. Focusing on the effect of sex
on autosomes, we identified 1,157 and 600 genes with
sex differences in the adult striatum and BNST/POA,
respectively. Interestingly, a substantial number of these
genes showed higher methylation in XY than XX. In the
striatum this proportion was 1,070/1,157 (92.48%) of
autosomal genes (Figure 2a). In the BNST/POA, 520/
600 (86.67%) genes were more methylated in XY relative
to XX during adulthood (Figure 2b). We next compared
the set of genes that showed sex-specific methylation in
each brain region to each other. Only genes that showed
sex-specific methylation differences at the same chromosomal location and in the same direction were considered to be common to both brain regions. Based on
these criteria, we found 362 genes, which we term dual
region sex-specific genes (Figure 2c). There was a substantial overrepresentation of X-linked genes (286/362
or 79%). Together, these data show that methylation status of many genes in the brain is subject to sex- and
region-specific regulation and that the process of X
inactivation largely affects the same genes in both the
striatum and the BNST/POA.
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Figure 2 CpG methylation at many genes is sexually dimorphic.
Displayed are the fractions of X and autosomal genes displaying
sexually dimorphic CpG methylation in (a) PN60 striatum and (b)
PN60 BNST/POA. (c) Genes with sexually dimorphic CpG methylation
at PN60 that are common to both the striatum and BNST/POA.
The Venn diagram shows the overlap (green) between sexually
dimorphic genes from the striatum (blue) and BNST/POA (yellow). The
numbers of genes belonging to each category are shown within the
relevant circles. The bar below the Venn diagram shows the percentage
of autosomal vs. X-linked genes in the overlap region.

Testosterone-induced modification of brain CpG methylation

Sex differences in methylation patterns can be attributed
to differences in sex hormones or to other influences
(e.g., direct genetic effects of the sex chromosomes). To
determine the effects of neonatal testosterone exposure
on CpG methylation genome-wide, we gave newborn female mice a masculinizing dose of testosterone (XX + T)
and compared their CpG methylation patterns to that of
control females (XX). The masculinizing effect of this
dose of testosterone was verified by examining the levator ani and bulbocavernosus muscles. These muscles
are androgen-sensitive and while they are present in
both sexes at birth [25], they die postnatally in females
due to the lack of testosterone. The maximal crosssectional area of the levator ani was measured in PN4
animals. Testosterone treatment resulted in a clear sparing of this muscle with it being five times larger in XX +
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T than in XX (269,150 ± 11,908 μm2 in XX + T vs.
53,721 ± 9,414 μm2 in XX; t = 13.6, p <0.0001) (Figure 3a;
Additional file 3: Table S3). Additionally, the bulbocavernosus muscle was absent in all XX animals examined
but preserved in all XX + T.
We found that neonatal testosterone exposure altered
the methylation status of a substantial number of genomic fragments. These fragments mapped to a relatively
small number of genes at PN4 (68 genes in the striatum
and 45 genes in the BNST/POA) (Figure 3b). However,
by day 60 of life, a much larger number of genes showed
methylation changes in response to neonatal testosterone (1,377 and 740 genes differed in methylation status
in testosterone-treated PN60 females relative to control
PN60 females in striatum and BNST/POA, respectively)
(Figure 3b; Additional file 3: Table S3). A substantial
fraction of these genes displayed increased 5-mC in response to testosterone. In the striatum, 51/68 (75.00%)
genes at PN4 and 1,324/1,377 (96.15%) genes at PN60
showed greater methylation in XX + T relative to XX
mice (Figure 3c). Similarly, in the BNST/POA 38/45
(84.44%) genes at PN4 and 705/740 (95.27%) genes at
PN60 also showed greater methylation in female mice
treated with testosterone (Figure 3c; Additional file 3:
Table S3).
Of the testosterone-affected genes, 654/1,377 (47.49%)
and 265/740 (35.81%) in the striatum and BNST/POA,
respectively, also exhibited male vs. female differences
in their methylation patterns at PN60 (Figure 3d,e;
p value = 1.00E − 111, hypergeometric test; fold enrichment over chance, 4.55 (striatum), 6.07 (BNST/POA);
Additional file 4: Table S4). There are several possible
reasons why many of the genes whose methylation
status was changed by testosterone did not show sex
differences: (1) a lack of statistical power such that
some differences are not confirmed in two different
comparisons, (2) a pharmacological effect of the relatively high dose of testosterone used here, or (3) testosterone effects found in XX but not normally in XY
mice. For some dependent measures, the presence of a
Y chromosome has effects opposite to that of testosterone [32]. In the current context, this means that some
effects of early exposure to androgens on CpG methylation in males may be masked by Y chromosome
factors.
To validate our RRBS findings, we performed traditional (Sanger) bisulfite sequencing. We chose one
testosterone-affected locus from each brain region for
validation. For the striatum, we chose Micall1 (higher
methylation in XX than XX + T). For the BNST/POA,
we chose Fzd9 (higher methylation in XX + T than
XX). The results from traditional bisulfite sequencing
were in agreement with the RRBS data (Additional
file 5: Figure S1).
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Brain region specificity of testosterone's effects

Next, we compared the testosterone-affected genes in
the striatum to those in the BNST/POA. As with our
identification of dual region sex-specific genes, only
genes where testosterone-affected methylation at the
same chromosomal location and in the same direction
were considered. At PN4, only two genes (Sorcs2 and
Lonrf3) were affected by testosterone in both the striatum and the BNST/POA (Figure 3f ). At PN60, this
number rose to 92, (neither Sorc2 nor Lonrf3 were
present in this list) (Figure 3g). Unlike the list of PN60
dual region sex-specific genes, the X chromosome was
not substantially over-represented in this comparison
(16 of the 92 dual region testosterone-affected genes
were X-linked). This result may be expected since in
both XX and XX + T animals, one X chromosome is expected to undergo inactivation and the same genes are
inactivated across tissues [33]. These data indicate that
testosterone's effects are more region-specific than that
of sex (as there are only 92 dual region testosteroneaffected genes compared to 362 sex-specific ones) and
that genetic sex has a much stronger effect on methylation of X-linked genes, whether they were subject to or
escaped X inactivation (compare Figure 2c to 3g).
In both the striatum and BNST/POA, the sexually
dimorphic gene sets showed a greater proportion of Xlinked genes compared to the testosterone-affected gene
sets (PN60 striatum, 26.6% vs. 6.1%; PN60 BNST/POA,
41.5% vs. 9.7%). When we consider just inactivation escapees, the results are largely similar to those from the
whole set. At both ages and in both brain regions, we
detected 5 of 14 known X inactivation escapees as being
sexually dimorphic in their methylation (1810030O07Rik,
6720401G13Rik, Bgn, Mid1, Shroom4) [34,35]. In contrast,
only 1 of these 14 (striatum, Mid1; BNST/POA,
6720401G13Rik) were affected by testosterone and
only at PN60. Thus, it appears that the effect of testosterone on X-linked genes is rather limited in both the
striatum and BNST/POA.
To examine the characteristics of testosterone-affected
genes in adulthood, we used Ingenuity Pathway Analysis
(IPA, Ingenuity Systems). Our analysis revealed that testosterone alters the methylation of genes belonging to a
wide range of biological processes and functions (Table 1;
Additional file 6: Table S5). Functional categories related
to nervous system development were strongly represented in the datasets from both the striatum and the
BNST/POA. Many of these functional categories were
common to both regions of the brain and represented
basic processes that are crucial for general neural function (for example, morphology of nervous tissue, neuritogenesis, guidance of axons, and morphology of dendritic
spines). Genes related to organization of cytoskeleton,
microtubule dynamics, and apoptosis were also altered
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Figure 3 Perinatal testosterone treatment affects CpG methylation at numerous loci. (a) The dose of testosterone given to female mice at
PN0 is masculinizing. Representative pictures of the levator ani (LA) are shown for PN4 XX (left panel) and XX + T (right panel). The muscle size is
reduced in the absence of testosterone. The arrows indicate the outline of the LA, which has a much larger surface area in XX + T than in XX
(269,150 ± 11,908 μm2 in XX + T vs. 53,721 ± 9,414 μm2 in XX; t = 13.6, p <0.0001). (b) Number of genes where methylation is altered in the XX
vs. XX + T comparison in PN4 and PN60 striatum and PN4 and PN60 BNST/POA. (c) Percentage of genes that exhibit testosterone-dependent hypo- or
hyper-methylation at each age in each tissue. (d, e) The Venn diagrams show the overlap (green) between genes with sexually dimorphic methylation
patterns (blue) and those that are affected by testosterone (yellow) in the (d) striatum and (e) BNST/POA. The numbers of genes belonging to each
category are shown within the relevant circles. (f, g) The number of genes that are affected by testosterone in both the striatum and the BNST/POA at (f)
PN4 and (g) PN60. The overlap between testosterone-affected genes from the striatum (blue) and BNST/POA (yellow) is shown in green. The numbers of
genes belonging to each category are shown within the relevant circles. The bar below the Venn diagram shows the percentage of autosomal vs. X-linked
genes in the overlap region.
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Table 1 Biological functions associated with differentially methylated genes in XX vs. XX + T mice determined by IPA
Category
Nervous system development
and function

Function annotation

Striatum

Morphology of nervous system

BNST/POA

p value

Number of genes

p value

Number of genes

1.02E − 08

108

3.91E − 06

63

Development of central nervous system

6.63E − 08

80

4.71E − 08

54

Morphology of nervous tissue

7.88E − 06

72

7.75E − 05

44

Neuritogenesis

1.05E − 05

48

1.03E − 07

37

Outgrowth of neurites

4.68E − 05

39

2.19E − 03

22

Coordination

4.69E − 05

31

1.67E − 02

15

Axonogenesis

1.48E − 04

24

1.18E − 04

17

Excitatory postsynaptic potential

1.51E − 04

18

5.55E − 03

10

Growth of neurites

1.75E − 04

41

5.21E − 03

23

Morphology of neurites

7.77E − 04

23

1.99E − 04

17

Morphology of dendritic spines

7.78E − 04

5

7.85E − 04

4

Guidance of axons

9.29E − 04

21

1.60E − 05

18

Outgrowth of axons

9.56E − 04

14

9.82E − 03

8

Neurotransmission

6.32E − 05

44

-

-

NMDA-mediated synaptic current

2.93E − 04

6

-

-

Action potential of cells

3.58E − 04

18

-

-

Long-term depression

1.30E − 03

13

-

-

Quantity of neurons

-

-

3.81E − 05

24

Cell viability of neurons

-

-

1.93E − 02

12

Organization of cytoskeleton

1.86E − 07

125

1.72E − 06

77

Microtubule dynamics

2.17E − 07

108

7.64E − 06

65

Skeletal and muscular system
development and function

Development of muscle

2.55E − 06

49

-

-

Cell death and survival

Apoptosis

7.68E − 06

250

1.70E − 03

138

Cellular growth and proliferation

Proliferation of neuronal cells

-

-

1.25E − 02

13

3.33E − 03

38

2.81E − 04

27

-

-

2.59E − 03

7

Cellular assembly and organization

Behavior

Learning
Social behavior

This table shows examples of functional categories enriched in the XX vs.
XX + T comparison for both the striatum and BNST/POA.

in adulthood by neonatal testosterone treatment in both
brain regions. We observed some biologically relevant
differences between the striatum and the BNST/POA. In
the XX vs. XX + T comparison, functional categories
uniquely enriched in the adult striatal dataset included
neurotransmission, NMDA-mediated synaptic current,
action potential of cells, long-term depression, and development of muscle. The striatum also showed an enrichment of functional categories related to neurological
disease (e.g., dyskinesia, Huntington's disease, hyperactive
behavior, seizures, mood disorder, ataxia, and amyotrophic lateral sclerosis) (Table 2). Functional categories
unique to the BNST/POA included quantity of neurons,
cell viability of neurons, and proliferation of neuronal
cells (Table 1). The presence of genes related to expansion and survival of neurons in the BNST/POA
testosterone-affected dataset is intriguing given the role

that cell death plays in the establishment of sex differences in this region [22] and recent evidence that cell
birth may be an important mechanism that helps maintain the sexual dimorphism in the sexually dimorphic
nucleus of the POA [36]. One effect of this cell death is
that cells sampled at PN4 in XX are most likely not the
same population as the cells sampled in adulthood.
Therefore, the methylation differences that we observe
might be a result of this change in the cellular population between the two time points studied.
We next examined the genomic features of fragments
identified by RRBS as differing between XX and XX + T
at PN60. In both brain regions, we found an underrepresentation of methylation changes not only in promoters
(defined as ±500 bp relative to the transcription start
site) but also in CpG islands. Gene-body methylation
(the entire gene from the transcription start site to the
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Table 2 Examples of top ‘neurological disease’ functional
categories that were significantly enriched in striatal
testosterone-influenced genes
Function annotation

p value

Number of genes

Movement disorder

1.03E − 04

118

Congenital anomaly of brain

6.81E − 04

26

Dyskinesia

3.36E − 03

73

Huntington's disease

3.43E − 03

70

Hyperactive behavior

3.47E − 03

18

Schizophrenia

3.90E − 03

56

Jervell and Lange-Nielsen syndrome

4.66E − 03

2

Seizures

5.08E − 03

33

Mood disorder

5.35E − 03

50

Hydrocephalus

6.76E − 03

11

Ataxia

6.89E − 03

22

Amyotrophic lateral sclerosis

7.00E − 03

18

Incoordination

9.03E − 03

3

Oligodendroglioma

9.64E − 03

5

Spina bifida

1.33E − 02

7

Degeneration of brain

1.34E − 02

8

Examples of top ‘neurological disease’ functional categories that were
significantly enriched in the list of testosterone-influenced genes (XX vs.
XX + T) in the striatum as determined by Ingenuity Pathway Analysis.

end of the transcript) contributed substantially to testosterone-altered CpGs. CpGs located within introns were most
susceptible to changes by testosterone (p value <1.00E − 94;
Fisher's exact test). Testosterone-modified CpGs were also
over-represented in exonic regions (p value <1.00E − 17;
Fisher's exact test). These results are consistent with recent
reports which suggest that in mammals, cell type-specific
CpG methylation-related gene regulation mostly occurs at
alternative promoters within gene bodies [37]. When we
compared the methylation patterns of three subclasses
of repetitive elements—short interspersed elements
(SINEs), long interspersed elements (LINEs), and simple
repeat regions—in our testosterone dataset, we detected a depletion of testosterone-affected CpG sites in
LINEs (p value <1.00E − 14; Fisher's exact test).
Identification of stably differentially methylated genes

To identify genes that showed stable differential methylation due to testosterone, we compared the genes that
showed differential methylation between XX vs. XX + T
at PN4 to the XX vs. XX + T genes at PN60. We defined
stably differentially methylated genes as those in which a
difference in CpG methylation at PN4 was also found at
PN60. We found a limited number of such genes (19
genes in the striatum and 11 genes in the BNST/POA)
(Table 3). About a third of these genes are X-linked but
none are known to escape X inactivation, implying that
testosterone does not affect X inactivation status. In 14/

19 genes in the striatum and 10/11 genes in the BNST/
POA, the magnitude of testosterone-driven changes in
methylation (delta methylation between XX and XX + T)
was similar at both PN4 and PN60. Except for a few
genes (three genes in the striatum and two genes in
the BNST/POA), the direction of the testosteronedependent epigenetic modifications remained the same
between PN4 and PN60. The majority of the locations
where stable testosterone-driven differential methylation
is observed are associated with multiple genomic features.
In both brain regions, the genomic feature most strongly
associated with stable methylation changes is gene bodies
(associated with 18/19 genes in the striatum and 11/11
genes in the BNST/POA). Next is methylation changes in
CpG islands (striatum, 11/19 genes, BNST/POA, 6/11
genes) and then promoter regions (striatum, 7/19 genes,
BNST/POA, 6/11 genes). Overall, the small number of
genes showing stable differential methylation indicates
that testosterone-induced methylation patterns are dynamic and can develop long after the initial exposure.

Testosterone-induced masculinization of methylation

We next assessed whether testosterone induces a broad
shift in CpG methylation in the brains of XX + T mice
from a female-typical to a more male-typical pattern.
We first identified CpG sites that were sexually dimorphic and defined them as those that displayed a significant difference in methylation levels between control
females and control males (p value ≤0.05 measured by
the Student's t test; FDR approximately 7% to 13%). This
analysis identified about 12,000–20,000 sites in each
brain region. For each site, we arbitrarily defined the
male methylation level as 0 and the female level as 100.
The XX + T methylation levels at these same sites were
normalized to this scale and graphed on a continuum
between 0 and 100.
Almost all the sexually dimorphic CpG sites were
more similar to females than males in the XX + T group
at PN4 in both the striatum and the BNST/POA
(Figure 4a,c); that is, testosterone treatment on the day
of birth had not masculinized the methylome by PN4.
However, by PN60, a large number of sexually dimorphic
CpG sites in both the striatum and BNST/POA demonstrated methylation levels more similar to males than to
females (p value <2.20E − 16, Kolmogorov-Smirnov test)
(Figure 4b,d). The shift toward male values was more pronounced in the striatum than in the BNST/POA (compare
Figure 4b to 4d). The distribution of sexually dimorphic
CpG sites in PN60 XX + T resembles a bimodal distribution (Figure 4b). These findings have two important implications. The first is that neonatal testosterone treatment of
females induces a clear shift to more masculine methylation
patterns that is only apparent as the animal ages. The
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Table 3 Testosterone-driven methylation changes at several genes are maintained into adulthood
Δ Me
at PN4

Fragment coordinate
at PN4

Δ Me
at PN60

Fragment coordinate
at PN60

4921515J06Rik

0.22

chr3:108742959-108743236

−0.13

chr3:108742959-108743236

Taf4b

−0.11

chr18:15048075-15048318

−0.1

chr18:15048075-15048318

X

F8a

−0.1

chrX:70473904-70474128

−0.13

chrX:70474305-70474419

X

X

Fmr1

−0.1

chrX:65932427-65932537

−0.11

chrX:65932427-65932537

X

X

Gene symbol

Associated genomic features
Prom

GB

CGI

X

X

Striatum
X

Kcnq1

0.28

chr7:150455734-150456023

−0.14

chr7:150481372-150481523

X

X

Rbbp7

−0.23

chrX:159198854-159199070

−0.12

chrX:159198688-159198839

X

X

X

Sox3

−0.11

chrX:58145676-58145842

−0.11

chrX:58146499-58146619

X

X

X

Dab1

−0.1

chr4:104298501-104298709

−0.11

chr4:104275571-104275789

Nnat

−0.13

chr2:157385832-157386011

−0.12

chr2:157386045-157386214

X

Arid3b

−0.19

chr9:57685767-57685957

−0.11

chr9:57685767-57685957

X

Grip1

−0.21

chr10:119402892-119403155

−0.12

chr10:119402892-119403155

Lonrf3

−0.1

chrX:33868422-33868652

−0.12

chrX:33869078-33869231

Clybl

−0.15

chr14:122662639-122662815

−0.12

chr14:122629995-122630146

X

Sorcs2

−0.13

chr5:36720053-36720329

−0.12

chr5:36511861-36512058

X

2610018G03Rik

−0.11

chrX:48194982-48195124

−0.12

chrX:48194982-48195124

Rap2c

−0.17

chrX:48370998-48371218

−0.12

chrX:48370998-48371218

Fndc3b

0.12

chr3:27382887-27383015

−0.21

chr3:27368716-27368995

X

Ubash3b

−0.12

chr9:40872064-40872268

−0.14

chr9:40872064-40872268

X

Foxk1

−0.25

chr5:142921051-142921281

−0.27

chr5:142921051-142921281

X

Igfbp7

−0.13

chr5:77809526-77809779

−0.21

chr5:77786342-77786589

X

Odz3

−0.11

chr8:49626485-49626755

0.12

chr8:49395012-49395267

X

Emd

−0.13

chrX:71500275-71500386

−0.11

chrX:71500067-71500242

X

X

X

Herc3

−0.12

chr6:58856760-58856872

−0.12

chr6:58856760-58856872

X

X

X

Commd1

−0.16

chr11:22873668-22873935

−0.12

chr11:22872579-22872758

X

X

X

Bcor

−0.14

chrX:11715730-11715985

−0.11

chrX:11703662-11703859

Nap1l5

−0.12

chr6:58856760-58856872

−0.12

chr6:58856760-58856872

Gpr179

−0.14

chr11:97193837-97194108

−0.11

chr11:97197795-97197992

Zrsr1

−0.16

chr11:22873668-22873935

−0.12

chr11:22872579-22872758

X

X

X

Lonrf3

−0.12

chrX:33868422-33868652

−0.1

chrX:33869078-33869231

X

X

X

Sdk1

−0.13

chr5:142590169-142590448

0.12

chr5:142312410-142312648

X

X

X

X

X

X

X

X

X

X

X

X

X

BNST/POA

X
X

X

X

X

X

Differential CpG methylation values between XX and XX + T at PN4 and PN60 are shown. Negative delta methylation indicates higher methylation in XX + T.
Genomic features associated with the differentially methylated region are indicated by the last three columns. An ‘X’ indicates that the fragment overlaps with a
feature (Prom promoter, GB gene body, CGI CpG island).

second is that the methylome of the striatum may be more
responsive to the effects of neonatal testosterone than the
BNST/POA. Additional file 7: Table S6 contains the full list
of masculinized genes.
Expression analysis

We also carried out transcriptome profiling on five biological replicates per experimental group using cDNA
microarrays. Each replicate consisted of a unique pool of
tissue from three animals from the same set of samples

used for methylomic analysis. After filtering for highquality expression data, 57 samples and 13,776 array
probes were retained for differential expression analysis.
According to principal component analysis (PCA), age and
brain region explained 78% and 48% of the expression variance, respectively, while experimental group differences
only explained up to 0.05% (Figure 5a; Additional file 8:
Table S7).
To identify genes with sex-specific expression patterns and those in which expression is regulated by
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Figure 4 CpG methylation patterns are more masculine in XX + T than XX at PN60. Mean XX + T methylation of the sites that display sizable basal
sex differences (delta methylation(XX-XY) ≥15%, p value ≤0.05) are plotted on a scale where 0 corresponds to XY and 100 corresponds to XX methylation
levels. At the bottom of each histogram the first number in the box represents the number of masculinized sites (methylation scale ≤50) divided by the
second number which is the number of total sites in the histogram. PN4 (a) and PN60 (c) striatum, PN4 (b), and PN60 BNST/POA (d). In both brain regions,
the PN60 distribution was significantly different from PN4 (p value <2.20E − 16, Kolmogorov-Smirnov test).

testosterone, we tested each of the possible pairwise
comparisons (XX vs. XY, XX vs. XX + T, XX + T vs.
XY) in different ages and brain regions. Significant
differential expression signals were only observed for
(1) XX vs. XY comparison at PN4 in BNST/POA (n = 5
per group, Benjamini-Hochberg (BH)-adjusted p value
(FDR) <0.05, 21 genes) and (2) XX vs. XX + T at PN60 in
the striatum (n = 5 per group, BH-adjusted p value (FDR)
<0.05, 99 genes) (Figure 5b,c). qRT-PCR was performed to
validate the microarray results. All genes detected as significantly different in the BNST/POA XX vs. XY PN4
microarray showed significant differences by PCR in the
expected direction (Additional file 5: Figure S2). We did
not have the biological material to validate the striatal XX
vs. XX + T PN60 microarray.
None of the genes in the striatal PN4 XX vs. XX + T
comparison survived BH adjustment. However, by day
60 of life, 99 genes demonstrated statistically significant
testosterone-dependent expression changes (BH-adjusted p value (FDR) <0.05). This finding was consistent
with the trend observed in the methylation data. In
addition, the gene expression differences associated with
testosterone treatment were less pronounced in the BNST/

POA than in the striatum in adulthood (Additional file 8:
Table S7). IPA analysis of differentially expressed genes in
XX vs. XX + T PN60 striatum showed enrichment of gene
categories such as formation of actin filaments, formation of
neurites, myelination of neurites, long-term potentiation,
and abnormal morphology of dopaminergic neurons
(Additional file 9: Table S8).
We next tested whether differentially expressed genes
also showed differential methylation. We identified a
number of genes where the CpG methylation state and
gene expression patterns correlated in the XX vs. XX + T
comparison in PN60 striatum. Of the 99 striatal genes
that were differentially expressed between XX and XX + T
at PN60, 10 genes also showed differential methylation
(Table 4). There were no genes that showed both differential expression and methylation in the BNST/POA.
Overall, we identified genes and pathways that are subject to regulation by testosterone at the mRNA level. Our
data suggest that testosterone regulates gene transcription
in a highly context-dependent manner (e.g., the effect of
testosterone appeared to be stronger in the striatum).
Finally, although some level of correlation was observed between methylation and expression changes,
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Figure 5 RNA samples cluster based on age and brain region differences. (a) Dendrogram representing hierarchical clustering of samples
based on 1-Pearson correlation of the genome-wide expression profiles. Red values are approximately unbiased (AU) p values, and green values are
bootstrap probability (BP) values. Values on the edges of the dendrogram are p values (%). Samples tended to cluster by age (PN4/PN60) and
brain region (striatum/BNST/POA). (b) p value distributions of comparison groups that demonstrated a significant differential expression signal
(PN4 XX vs. XY BNST/POA and PN60 XX vs. XX + T striatum). (c) Each bar plot represents the log2 fold changes in gene expression of the top 20
upregulated and downregulated probe sets. For each plot the relative gene expression fold changes are shown for the XY or XX + T relative to
the XX. Positive fold change values represent increased expression in XY or XX + T relative to XX mice.

the genes identified by these two analyses were largely
non-overlapping. The ability of methylation differences to predict expression changes at the single gene
level was limited.

Discussion
Our study shows that the organizational effect of testosterone on the brain is late-emerging and markedly modifies the epigenetic CpG methylation landscape of the
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Table 4 Genes that show testosterone-driven changes in
both CpG methylation and gene expression
Gene
Ppp2r5c

Log2 fold
change

Expression difference
p value

Δ Me at
PN60

1.07

9.66E − 05

0.10

Nrxn1

0.95

3.63E − 04

0.10

Lpin1

0.71

8.18E − 05

0.10

Egln1

0.53

2.41E − 04

0.13

Bin1

0.47

2.08E − 04

0.11

Inpp5a

0.42

3.80E − 04

−0.13

Fhl1

0.40

4.11E − 05

0.15

Mras

−0.42

3.09E − 04

0.13

E130203B14Rik

−0.61

2.75E − 04

0.12

Wfdc1

−0.66

1.26E − 04

0.10

Genes that show testosterone-driven changes in both CpG methylation and
gene expression in the PN60 XX vs. XX + T comparison in the striatum. Negative values in the second column indicate lower expression in XX + T relative to
XX. In the fourth column, negative values indicate lower methylation in XX + T
relative to XX.

brain. We have established the first genome-wide and
quantitative map of testosterone-induced CpG methylation changes in two sexually dimorphic brain regions.
We show that the majority of methylation changes
caused by testosterone are not established in the first
few days following the initial exposure to testosterone.
Instead, testosterone's effects are most obvious in adulthood where it has masculinized a large number of
sexually dimorphic CpG sites, which show increased
methylation in XX + T and XY compared to XX. These
results run counter to our initial prediction that sex differences in methylation are established during early development, most of which remain stable over time. Since
the organizational effects of testosterone appear much
later in life, organization by testosterone may occur via
early programming on relatively few genes. This small
initial effect is what sets up the brain to respond in a
particular fashion to other events during postnatal
development. Since all animals in the study were gonadectomized before puberty and provided with identical
hormone replacement prior to sacrifice, differences seen
during adulthood likely reflect programming by perinatal
testosterone. However, the full manifestation of these
differences may require the presence of testosterone in
adulthood.
All animals were given T implants at PN45 to capture the full effect of perinatal organization. Previous
studies had shown that the full manifestation of some
organizational effects requires activational hormonal effects
(in other words, adult levels of circulating hormone levels).
For instance, female rats given testosterone perinatally will
not show increased mounting behavior unless they are also
given a dose of testosterone in adulthood [38]. Therefore,

we hypothesized that the effects of perinatal T on the
methylome would not fully manifest themselves unless
adult circulating hormonal levels were also present. If
no hormone replacement had taken place, it is likely
that we would have found fewer differences between
XX and XX + T. It is also likely that the XX + T animals would have experienced less masculinization of
their methylomes.
Another unexpected finding with respect to the testosterone effects is that the shift toward a male-like pattern
of CpG methylation in XX + T mice was more pronounced in the striatum than in the BNST/POA. This
was surprising since the BNST/POA displays some of the
most prominent anatomical and neurochemical sex
differences in the brain that result from organization
by gonadal hormones, whereas sex differences in the
striatum are comparatively modest in terms of neuroanatomy. Our data therefore show that neuroanatomical
and neurochemical markers of sex differences may not
fully reflect the sensitivity of a brain region to gonadal
hormones.
We also identified sets of testosterone-regulated loci
that clearly maintained differences in 5-mC from PN4 to
PN60 in both the striatum and BNST/POA, although
these were a small minority. The overwhelming majority
of testosterone-affected loci showed dynamic CpG methylation patterns. While this is not in agreement with
the classic view of DNA methylation as a permanent
epigenetic mark, our data are consistent with the findings of several recent studies demonstrating developmental or experience-dependent regulation of 5-mC in
the mammalian brain [39-43]. For example, Schwarz
et al. have shown that sex differences in methylation patterns at the Esr1, Esr2, and Pr promoters are dynamic
across the life span [15]. Although, we did not identify
the methylation patterns of Esr1, Esr2, and Pr promoters
as significantly influenced by sex or testosterone exposure, we were not surprised given the different species
used in each study (mice in our study and rats in
Schwarz et al.), the difference in tissue examined (both
the BNST and POA here vs. just the POA in Schwarz
et al.), and the fact that we required our differentially
methylated fragments to show consistent methylation
changes in several adjacent CpG sites (Schwarz et al.
considered each CpG site on its own).
When we examined the characteristics of the genes associated with the testosterone-modified CpGs, we found
a significant enrichment of genes that are expressed in
the brain, particularly those involved in synaptic function.
This suggests that the effect of the neonatal testosterone is
not random and that testosterone specifically alters
the methylation of neural-related genes. Furthermore,
the effects of testosterone (particularly on X-linked genes)
appear to be brain region-specific. Interestingly, among
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the genes that were differentially methylated in the striatum due to testosterone, a substantial number encoded
signaling components associated with increased or decreased risk of Parkinson's disease. We found that these
genes overlapped with genes that show strong sex differences in expression in dopaminergic neurons from Parkinson's disease patients [44].
In the BNST/POA, sexually differentiated rates of
apoptosis (male < female) driven by testosterone exposure is one of the major events leading to the volumetric
sex differences in this region during the sensitive period
[22,45]. Consistent with this, we found genes involved
in apoptosis in the testosterone-affected dataset at
both PN4 and PN60. Perhaps most intriguing, we had
genes related to the proliferation of neuronal cells in
our dataset. Recent evidence has shown that the
maintenance of sexual dimorphism resulting from the
organizational effects of testosterone may require reinforcement in the form of pubertal hormones [36,46,47].
At least some of this reinforcement may take the
form of sexually differentiated cell addition in several
sexually dimorphic brain regions including the POA
[36,48,49].
In studying the genome-wide methylation profiles of
the striatum and BNST/POA both neonatally and later
in life, we found that the methylation patterns of a large
number of genes differed between the two sexes. Maleto-female comparisons displayed a marked enrichment
of methylation on the X chromosome in females which
could potentially be accounted for by X chromosome inactivation. Most of the X-linked genes that showed sexspecific differences in CpG methylation were found in
both brain regions. This strongly suggests that the
methylation differences we are detecting are real as the
process of X inactivation affects X-linked genes similarly
across tissues [34]. We also identified widespread autosomal gene methylation differences between males and
females. In contrast to the results from X-linked genes,
the vast majority of autosomal genes that show sex differences were unique to either the striatum or the
BNST/POA. Most of these genes were more methylated
in males. One possible explanation is that the inactivated
X chromosome could potentially act as a ‘heterochromatin sink,’ sequestering the factors required for gene silencing (DNA methyltransferases, etc.) at autosomal loci
[50-52].
Most interestingly, concordant with the findings from
our analysis of CpG methylation in the striatum, we
found that testosterone's effect on gene expression was
late-emerging. Finally, when we explored the extent to
which changes in methylation levels contributed to gene
expression differences, we found evidence for correlations between gene expression patterns and methylation
profiles at some genes associated with DMRs, but in
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general, methylation differences did not predict differences in gene expression. This observation may not be
surprising given that we worked with tissues that were
relatively heterogeneous. In addition, many CpG methylation differences may not be associated with gene expression changes. Lyko et al. showed that there is a
strong correlation between CpG methylation and splicing sites including those that have the potential to yield
alternative exons [53]. Therefore, an interesting avenue
of research will be determining whether testosteroneinduced methylation differences can specifically regulate
splicing, rather than transcription.
There are several limitations to this study. This
work represents a snapshot of the DNA methylation
landscape at two ages, while the brain may display a
vast array of epigenetic states as it passes through different
stages of development. Longitudinal study designs examining DNA methylation at different life stages could provide a comprehensive picture of how the epigenome
is modified over time. Because testosterone is known
to alter the proportion of specific cell types comprising
the BNST/POA and possibly the striatum, group differences in levels of methylation reported here could be the
result of testosterone- or sex-specific regulation of the cell
types in the dissected tissue, which in turn differ in
their methylation of specific genes, or could reflect
direct testosterone effects on the methylome of cell
types common to the different groups. In addition,
DNA methylation is associated with other epigenetic
alterations, especially histone modifications and RNAi
pathways. Studies of these other epigenetic changes
are crucial to identifying common mechanisms underlying sex differences in epigenetic regulation. Finally,
different brain regions are expected to display different epigenetic marks across their genomes, and epigenetic profiling across functionally discrete brain
areas will be important in identifying tissue-specific sex
differences.

Conclusions
Taken together, our results suggest that early testosterone exposure has broad effects on brain methylation
patterns particularly during adulthood and that the
emergence of sex differences in the brain may be a gradual process that is cemented over the organism's life.
Our data provide a new perspective by showing that
most sex differences in CpG methylation are dynamic
and not the result of acute modifications in response to
hormones. Clearly, additional studies of genome-scale
methylation maps will be important to give us a full
understanding of the long-lasting influences of early
hormone exposure on DNA methylation dynamics of
the brain.
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Additional files
Additional file 1: Table S1. Summary information for all individual
striatum and BNST/POA samples included in this study. To enable our
comparison, RRBS libraries were sequenced and aligned to the mouse
mm9 genome. Twelve striatum RRBS and twelve BNST/POA RRBS libraries
(125 million total reads, average coverage of 58×, and 46% mapability)
were chosen for comparison, and summary statistics are shown.
Genome coverage represents the number of CpG sites in the genome
calculated on both strands. Fragment coverage reflects the number
of CpG sites in the fragments of sizes 100 to 300. Data coverage
is the number of CpG sites covered by at least one read, and
analysis coverage refers to the number of CpG sites covered by
at least four reads.
Additional file 2: Table S2. Genes demonstrating differential
methylation in XX vs. XY animals. Differential methylation is defined by a
z-score threshold that results in a false discovery rate less than 10% and
DNA methylation difference >10% as represented by delta methylation.
Negative delta methylation values represent increased methylation
in XX.
Additional file 3: Table S3. Differentially methylated genes in the
testosterone dataset (XX vs. XX + T). Differential methylation is defined by
a z-score threshold that results in a false discovery rate less than 10% and
DNA methylation difference >10% as represented by delta methylation.
Negative delta methylation values represent increased methylation levels
in XX + T relative to XX mice.
Additional file 4: Table S4. Genes whose methylation patterns were
different between the XX and XX + T and between the XX and XY
animals. Differential methylation is defined by a z-score threshold that
results in a false discovery rate less than 10% and DNA methylation
difference >10% as represented by delta methylation. Negative delta
methylation values in the XX vs. XX + T columns represent increased
methylation in XX + T relative to XX. In the XX vs. XY dataset, negative
delta methylation values represent increased methylation in XX
relative to XY.
Additional file 5: Validation of RRBS and microarray results.
Figure S1. Validation of RRBS data by traditional (Sanger) bisulfite
sequencing. One locus from each brain region that showed both
testosterone-affected and sex-specific methylation differences at PN60 was
selected for validation (for the striatum, Micall1; BNST/POA: Fzd9). n = 2–3 per
group. Figure S2. qPCR validation of genes that were detected as significantly
differentially expressed between XX and XY in the BNST/POA at PN4.
Error bars represent the standard error of the mean from 3 to 4
biological replicates from each group. Expression is relative to GAPDH
and is normalized to XX.
Additional file 6: Table S5. Ingenuity Pathway Analysis (IPA, www.
ingenuity.com) was performed on the entire dataset of genes whose
methylation was affected by testosterone at PN60 in striatum and BNST/
POA. The IPA networks, functions, and canonical pathways enriched in
this dataset are provided in separate tabs.
Additional file 7: Table S6. Genes associated with CpG sites where
methylation was masculinized by testosterone in the XX + T group.
Genes were deemed masculinized if they contained at least one CpG site
in either the gene body or the promoter demonstrating more male
typical methylation patterns.
Additional file 8: Table S7. Lists of differentially expressed genes
between XX vs. XX + T and between XX vs. XY in striatum and BNST/POA
at both time points (n = 5 per group, Benjamini-Hochberg-adjusted p
value <0.05). Negative fold change values represent decreased expression
in XX + T or XY relative to XX mice.
Additional file 9: Table S8. Ingenuity Pathway Analysis of genes
associated with XX vs. XX + T comparison at PN60 in the striatum. The
IPA networks, functions, and canonical pathways enriched in this dataset
are provided in separate tabs.
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